Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01626014 · ClinicalTrials.gov registry record · Early Phase 1
Interactive Educational Website for Women With Ovarian Cancer & Caregivers
A Early Phase 1 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 53
- Enrollment target
NCT01626014: Completed Early Phase 1 study, sponsored by University of Minnesota.
NCT01626014 is a Early Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 53 participants, roughly in line with the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01626014, a Early Phase 1 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 53 participants
- Enrollment target
Study Summary
Ovarian cancer accounts for more deaths than any other gynecologic malignancy. The majority of patients are diagnosed with Stage III-IV disease. Nearly 80% of these patients will recur resulting in 5-year survival rates of 14-32%. Although enrollment is increasing in hospice, hospice programs have been challenged to reach eligible patients. Several factors limit the number of people who enroll in hospice and the length of their hospice stay. Prognostication challenges and the increasing availability of cancer therapies for people with cancer set the stage for a mismatch between certification of a 6 month prognosis and contemporary medical care. Additionally patients often are not aware of hospice and the services they can provide.
Primary Outcome
Count of number of women with ovarian cancer who completed a new or updated their Advanced Directive during the study period.
Interventions
- BEHAVIORAL Usual Care Educational Website
- BEHAVIORAL Prototype System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2012-08 |
| Est. Completion | 2014-12 |
| Phase | Early Phase 1 |
What the finished NCT01626014 record still lists
NCT01626014 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, roughly in line with the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Usual Care Educational Website is the first listed.
NCT01626014 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01626014 about?
NCT01626014 is a clinical study titled "Interactive Educational Website for Women With Ovarian Cancer & Caregivers". Ovarian cancer accounts for more deaths than any other gynecologic malignancy. The majority of patients are diagnosed with Stage III-IV disease. Nearly 80% of these patients will recur resulting in 5-year survival rates of 14-32%. Although enrollment is increasing in hospice, hospice programs have b...
What is the current status of trial NCT01626014?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 53 participants. The study started on 2012-08. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01626014?
The interventions under investigation include: Usual Care Educational Website (BEHAVIORAL), Prototype System (BEHAVIORAL).
Who is sponsoring clinical trial NCT01626014?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01626014's enrollment target sits among peer trials
53 472nd of 2000 higher than 1,525 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia